CN104883907B - 含有鞘磷脂的补充剂 - Google Patents

含有鞘磷脂的补充剂 Download PDF

Info

Publication number
CN104883907B
CN104883907B CN201380068518.2A CN201380068518A CN104883907B CN 104883907 B CN104883907 B CN 104883907B CN 201380068518 A CN201380068518 A CN 201380068518A CN 104883907 B CN104883907 B CN 104883907B
Authority
CN
China
Prior art keywords
solid supplement
solid
mass
supplement
phosphatidylinositol
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
CN201380068518.2A
Other languages
English (en)
Chinese (zh)
Other versions
CN104883907A (zh
Inventor
新井阳
新井阳一
石田悠记
盐屋靖
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Kao Corp
Original Assignee
Kao Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kao Corp filed Critical Kao Corp
Publication of CN104883907A publication Critical patent/CN104883907A/zh
Application granted granted Critical
Publication of CN104883907B publication Critical patent/CN104883907B/zh
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/66Phosphorus compounds
    • A61K31/683Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/115Fatty acids or derivatives thereof; Fats or oils
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/66Phosphorus compounds
    • A61K31/683Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols
    • A61K31/688Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols both hydroxy compounds having nitrogen atoms, e.g. sphingomyelins
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2013Organic compounds, e.g. phospholipids, fats
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2013Organic compounds, e.g. phospholipids, fats
    • A61K9/2018Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0053Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Food Science & Technology (AREA)
  • Mycology (AREA)
  • Polymers & Plastics (AREA)
  • Nutrition Science (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
CN201380068518.2A 2012-12-28 2013-12-27 含有鞘磷脂的补充剂 Active CN104883907B (zh)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2012-288219 2012-12-28
JP2012288219 2012-12-28
PCT/JP2013/085161 WO2014104316A1 (ja) 2012-12-28 2013-12-27 スフィンゴミエリン含有サプリメント

Publications (2)

Publication Number Publication Date
CN104883907A CN104883907A (zh) 2015-09-02
CN104883907B true CN104883907B (zh) 2017-05-17

Family

ID=51021385

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201380068518.2A Active CN104883907B (zh) 2012-12-28 2013-12-27 含有鞘磷脂的补充剂

Country Status (7)

Country Link
US (1) US9649322B2 (enExample)
EP (1) EP2939550B1 (enExample)
JP (2) JP5701371B2 (enExample)
CN (1) CN104883907B (enExample)
MY (1) MY171853A (enExample)
SG (1) SG11201505131UA (enExample)
WO (1) WO2014104316A1 (enExample)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP6484975B2 (ja) * 2014-09-24 2019-03-20 日油株式会社 グリセロリン脂質含有粉末および健康食品
TWI882193B (zh) * 2020-11-30 2025-05-01 日商花王股份有限公司 固形組合物

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2000139410A (ja) 1998-11-06 2000-05-23 Kansai Koso Kk 炊飯用カルシウム強化剤
US6441050B1 (en) * 2000-08-29 2002-08-27 Raj K. Chopra Palatable oral coenzyme Q liquid
WO2002038575A1 (en) 2000-11-07 2002-05-16 I.R.B. Istituto Di Ricerche Biotecnologiche S.R.L. Glycerophosphoinositol derivatives as modulators of cytosolic a2 phospholipase
JP4568464B2 (ja) 2001-11-07 2010-10-27 雪印乳業株式会社 記憶障害予防治療剤
JP2004155682A (ja) 2002-11-05 2004-06-03 Dai Ichi Kogyo Seiyaku Co Ltd 錠剤用滑沢剤組成物
GB0322448D0 (en) 2003-09-25 2003-10-29 Lamellar Therapeutics Ltd Using lamellar bodies to modify linear biological macro molecules
EP1898722B1 (en) 2005-04-28 2013-04-10 Enzymotec Ltd. Polar lipid mixtures, their preparation and uses
PT1901620T (pt) 2005-05-31 2020-09-28 Arla Foods Amba Frações de leite enriquecido com fosfatidiliserina para a formulação de alimentos funcionais
JP5179737B2 (ja) 2005-09-22 2013-04-10 雪印メグミルク株式会社 スフィンゴミエリン含有医薬
JP2007246404A (ja) 2006-03-14 2007-09-27 Snow Brand Milk Prod Co Ltd 学習能向上剤
NZ566842A (en) 2005-09-22 2011-12-22 Megmilk Snow Brand Co Ltd Use of sphingomyelin for preventing or reducing alcohol intoxication and/or hangover
KR20090037404A (ko) 2006-07-05 2009-04-15 카오카부시키가이샤 근력 향상제
JP2008031148A (ja) 2006-07-05 2008-02-14 Kao Corp 筋力向上剤
JP5208428B2 (ja) 2007-01-30 2013-06-12 雪印メグミルク株式会社 美肌剤
JP5281268B2 (ja) 2007-10-31 2013-09-04 花王株式会社 筋力向上剤
JP5465834B2 (ja) 2008-01-15 2014-04-09 雪印メグミルク株式会社 肝機能保護剤
JP5882559B2 (ja) * 2008-08-07 2016-03-09 花王株式会社 運動機能向上剤
US20100151037A1 (en) * 2008-08-07 2010-06-17 Yivan Jiang Method for the preparation of nanoparticles containing a poorly water-soluble pharmaceutically active compound
JP2010111608A (ja) 2008-11-05 2010-05-20 Kao Corp 筋損傷抑制剤
US8268360B2 (en) * 2010-08-26 2012-09-18 Kao Corporation Motor function improver

Also Published As

Publication number Publication date
EP2939550A4 (en) 2016-11-02
SG11201505131UA (en) 2015-08-28
JP5701371B2 (ja) 2015-04-15
EP2939550A1 (en) 2015-11-04
US9649322B2 (en) 2017-05-16
EP2939550B1 (en) 2018-11-21
WO2014104316A1 (ja) 2014-07-03
JP2015083594A (ja) 2015-04-30
US20150342971A1 (en) 2015-12-03
MY171853A (en) 2019-11-05
CN104883907A (zh) 2015-09-02
JP2014141476A (ja) 2014-08-07

Similar Documents

Publication Publication Date Title
JP6014493B2 (ja) 固形状組成物
CN105360879B (zh) 用于压片的包埋液体润滑剂
KR101371877B1 (ko) 구강내 붕괴형 n-아세틸글루코사민 정제 및 그의제조방법
ES2665520T3 (es) Composiciones de celulosa microcristalina y fosfato cálcico útiles como excipientes farmacéuticos
JP2016174616A (ja) 崩壊性組成物及び易崩壊性圧縮成型物
CN104883907B (zh) 含有鞘磷脂的补充剂
JP6351934B2 (ja) 食品用口腔内崩壊錠剤の製造方法
TWI552754B (zh) Solid composition
CN102480998A (zh) 赤藓醇和异麦芽酮糖醇的压片
JP6554034B2 (ja) カルシウム剤
CN109090319A (zh) 乳矿物盐压片糖果
JP2020117503A (ja) 経口組成物
JP6608193B2 (ja) 固形状組成物
JP2022003093A (ja) 圧縮成型製剤
JP5160156B2 (ja) 栄養機能食品錠剤
JP2017154974A (ja) グリセロリン脂質含有粉末及びこれを含む錠剤
JP6251667B2 (ja) 錠剤型即放性製剤及びその製造方法
JP7334025B2 (ja) グルコサミンがカルシウム化合物で被覆されている経口組成物
JP5772169B2 (ja) イプリフラボン含有直打錠剤
JP2023119660A (ja) 錠剤用基材、錠剤の崩壊促進用組成物、口腔用錠剤の食感および/または食味改良用組成物ならびに錠剤の製造方法
JP6669576B2 (ja) 固形状組成物
JP2003267867A (ja) テアニン含有圧縮成形物、製造方法および用途
JP2003081823A (ja) 粉末タウリン製剤組成物および用途

Legal Events

Date Code Title Description
PB01 Publication
EXSB Decision made by sipo to initiate substantive examination
SE01 Entry into force of request for substantive examination
GR01 Patent grant
GR01 Patent grant